Literature DB >> 26949278

Manifestation of neuronal ceroid lipofuscinosis in Australian Merino sheep: observations on altered behaviour and growth.

Greg M Cronin1, Danai F Beganovic1, Amanda L Sutton1, DavidJ Palmer1, Peter C Thomson1, Imke Tammen1.   

Abstract

Neuronal ceroid lipofuscinoses (NCL) is an inherited neurodegenerative disorder in children. Presently there is no effective treatment and the disorder is lethal. NCL occur in a variety of non-human species including sheep, which are recognised as valuable large animal models for NCL. This experiment investigated the progressive postural, behavioural and liveweight changes in NCL-affected lambs, to establish practical, non-invasive biomarkers of disease progression for future preclinical trials in a CLN6 Merino sheep model. A flock of eight lambs at pasture was studied, with the observer blind to the disorder status. Three genotypes were compared: homozygous affected NCL; n = 4), clinically normal heterozygous (Carrier; n = 2) and homozygous normal (non-carrier control (Normal); n = 2). Direct observation during daylight and continuous accelerometer measurements over 72 h were used to quantify lamb posture and behaviour in 11 sessions between 26-60 weeks of age, conducted at 3-5 week intervals. There was a Genotype (G) × Age (A) interaction (P = 0.001) for liveweight of the lambs in the experiment, with NCL, Carrier and Normal lambs gaining 11.8, 16.5 and 23.4 kg, respectively, between 26 and 60 weeks of age. G×A interactions were also found for walking behaviour (means for NCL, Carrier and Normal genotype groups at 26 and 60 weeks, were 1.7 and 7.9%, 3.3 and 3.1%, and 2.5 and 1.9% of observations, P = 0.008) and a composite variable of key behaviours identified in the principal components analysis (P < 0.001), with mean values for NCL lambs increasing three-fold compared to non-affected lambs as age increased. Similarly, NCL lambs became less responsive to visual and auditory stimuli as they aged. Mean responsiveness scores (out of 3) to visual stimuli for the NCL, Carrier and Normal genotypes at 26 and 60 weeks of age were 2.7 and 1.4, 2.8 and 2.9, and 3.0 and 3.0, respectively (G × A, P < 0.001). Changes in response to auditory stimuli were similar to visual stimuli. NCL lambs took more (P = 0.015) steps per 24 h than Carrier and Normal genotype lambs, but there was no G × A interaction. At 26 and 60 weeks of age respectively, NCL lambs took 2724 and 4121 steps per 24 h, compared to Carrier (1708 and 3105 steps) and Normal genotype lambs (2109 and 3506 steps). NCL lambs also performed less (P = 0.018) grazing behaviour than Carrier and Normal genotype lambs (66.5, 72.3 and 72.5% of observations for NCL, Carrier and Normal lambs, respectively). A number of behavioural changes identified in the experiment could form the basis for a protocol for monitoring and evaluation of disease progression.

Entities:  

Keywords:  Animal model; Behavioural indicators; Genetics; Neurodegenerative disease; Sheep

Year:  2016        PMID: 26949278      PMCID: PMC4776667          DOI: 10.1016/j.applanim.2015.11.012

Source DB:  PubMed          Journal:  Appl Anim Behav Sci        ISSN: 0168-1591            Impact factor:   2.448


  19 in total

1.  New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses.

Authors:  Ruth E Williams; Sara E Mole
Journal:  Neurology       Date:  2012-07-10       Impact factor: 9.910

2.  A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA.

Authors:  Imke Tammen; Peter J Houweling; Tony Frugier; Nadia L Mitchell; Graham W Kay; Julie A L Cavanagh; Roger W Cook; Herman W Raadsma; David N Palmer
Journal:  Biochim Biophys Acta       Date:  2006-09-12

3.  Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6).

Authors:  Manfred J Oswald; David N Palmer; Graham W Kay; Stephen J A Shemilt; Payam Rezaie; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2005-10       Impact factor: 5.996

Review 4.  Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.

Authors:  Varun Warrier; Mariana Vieira; Sara E Mole
Journal:  Biochim Biophys Acta       Date:  2013-03-28

5.  A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration.

Authors:  J Tyynelä; I Sohar; D E Sleat; R M Gin; R J Donnelly; M Baumann; M Haltia; P Lobel
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

6.  The effects of 12, 30, or 48 hours of road transport on the physiological and behavioral responses of sheep.

Authors:  A D Fisher; D O Niemeyer; J M Lea; C Lee; D R Paull; M T Reed; D M Ferguson
Journal:  J Anim Sci       Date:  2010-02-12       Impact factor: 3.159

7.  Neuronal ceroid-lipofuscinosis in Borderdale sheep.

Authors:  R D Jolly; D G Arthur; G W Kay; D N Palmer
Journal:  N Z Vet J       Date:  2002-10       Impact factor: 1.628

Review 8.  Use of model organisms for the study of neuronal ceroid lipofuscinosis.

Authors:  Michael Bond; Sophia-Martha Kleine Holthaus; Imke Tammen; Guy Tear; Claire Russell
Journal:  Biochim Biophys Acta       Date:  2013-01-18

9.  Lysosomal dysfunction results in altered energy balance.

Authors:  Josh C Woloszynek; Trey Coleman; Clay F Semenkovich; Mark S Sands
Journal:  J Biol Chem       Date:  2007-10-02       Impact factor: 5.157

10.  Ovine ceroid-lipofuscinosis: a model of Batten's disease.

Authors:  R D Jolly; A Janmaat; D M West; I Morrison
Journal:  Neuropathol Appl Neurobiol       Date:  1980 May-Jun       Impact factor: 8.090

View more
  2 in total

1.  Natural history of retinal degeneration in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses.

Authors:  S J Murray; N L Mitchell
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

2.  Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep.

Authors:  Hemanth R Nelvagal; Samantha L Eaton; Sophie H Wang; Elizabeth M Eultgen; Keigo Takahashi; Steven Q Le; Rachel Nesbitt; Joshua T Dearborn; Nicholas Siano; Ana C Puhl; Patricia I Dickson; Gerard Thompson; Fraser Murdoch; Paul M Brennan; Mark Gray; Stephen N Greenhalgh; Peter Tennant; Rachael Gregson; Eddie Clutton; James Nixon; Chris Proudfoot; Stefano Guido; Simon G Lillico; C Bruce A Whitelaw; Jui-Yun Lu; Sandra L Hofmann; Sean Ekins; Mark S Sands; Thomas M Wishart; Jonathan D Cooper
Journal:  J Clin Invest       Date:  2022-10-17       Impact factor: 19.456

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.